{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:49:10Z","timestamp":1792705750531,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/nrrheum.2016.218","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T09:29:55Z","timestamp":1486027795000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases"],"prefix":"10.1038","volume":"13","author":[{"given":"Medya M.","family":"Shikhagaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Germar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Romero","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"BFnrrheum2016218_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293\u2013301 (2015).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR2","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jaci.2016.09.009","volume":"138","author":"J Mj\u00f6sberg","year":"2016","unstructured":"Mj\u00f6sberg, J. & Spits, H. J. Human innate lymphoid cells. J. Allergy Clin. Immunol. 138, 1265\u20131276 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum2016218_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","volume":"41","author":"CJ Oliphant","year":"2014","unstructured":"Oliphant, C. J.  et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41, 283\u2013295 (2014).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/all.12446","volume":"69","author":"LY Drake","year":"2014","unstructured":"Drake, L. Y., Lijima, K & Kita, H. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice. Allergy 69, 1300\u20131307 (2014).","journal-title":"Allergy"},{"key":"BFnrrheum2016218_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","volume":"40","author":"TY Halim","year":"2014","unstructured":"Halim, T. Y.  et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425\u2013435 (2014).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ni.3294","volume":"17","author":"TY Halim","year":"2016","unstructured":"Halim, T. Y.  et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory Th2 cell responses. Nat. Immunol. 17, 57\u201364 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4049\/jimmunol.1402534","volume":"194","author":"N Krishnamoorthy","year":"2015","unstructured":"Krishnamoorthy, N.  et al. Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J. Immunol. 194, 863\u2013867 (2015).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aaa4812","volume":"348","author":"MR Hepworth","year":"2015","unstructured":"Hepworth, M. R.  et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells. Science 348, 1031\u20131035 (2015).","journal-title":"Science"},{"key":"BFnrrheum2016218_CR9","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.34355","volume":"64","author":"F Ciccia","year":"2012","unstructured":"Ciccia, F.  et al. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum. 64, 1869\u20131878 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016218_CR10","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia, F.  et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann. Rheum. Dis. 74, 1739\u20131747 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016218_CR11","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/jid.2014.146","volume":"134","author":"MB Teunissen","year":"2014","unstructured":"Teunissen, M. B.  et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR+ ILC3 in lesional skin and blood of psoriasis patients. J. Invest. Dermatol. 134, 2351\u20132360 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrrheum2016218_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink, J. H.  et al. Interleukin-12 and -23 control plasticity of CD127 group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146\u2013160 (2015).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5114\/ceji.2015.56971","volume":"40","author":"K Popko","year":"2015","unstructured":"Popko, K. & G\u00f3rska, E. The role of natural killer cells in pathogenesis of autoimmune diseases. Cent. Eur. J. Immunol. 40, 470\u2013476 (2015).","journal-title":"Cent. Eur. J. Immunol."},{"key":"BFnrrheum2016218_CR14","first-page":"215","volume":"381","author":"CS Klose","year":"2014","unstructured":"Klose, C. S. & Diefenbach, A. Transcription factors controlling innate lymphoid cell fate decisions. Curr. Top. Microbiol. Immunol. 381, 215\u2013255 (2014).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnrrheum2016218_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CS Klose","year":"2014","unstructured":"Klose, C. S.  et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340\u2013356 (2014).","journal-title":"Cell"},{"key":"BFnrrheum2016218_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","volume":"30","author":"H Spits","year":"2012","unstructured":"Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647\u2013675 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2016218_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","volume":"41","author":"AN McKenzie","year":"2014","unstructured":"McKenzie, A. N., Spits, H. & Eberl, G. Innate lymphoid cells in inflammation and immunity. Immunity 41, 366\u2013374 (2014).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs, A.  et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38, 769\u2013781 (2013).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR19","doi-asserted-by":"publisher","first-page":"e22459","DOI":"10.1371\/journal.pone.0022459","volume":"6","author":"P Songhet","year":"2011","unstructured":"Songhet, P.  et al. Stromal IFN-\u03b3R-signaling modulates goblet cell function during Salmonella typhimurium infection. PLoS ONE 6, e22459 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2016218_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","volume":"17","author":"CS Klose","year":"2016","unstructured":"Klose, C. S. & Artis, D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat. Immunol. 17, 765\u2013774 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR21","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1084\/jem.20051615","volume":"203","author":"PG Fallon","year":"2006","unstructured":"Fallon, P. G.  et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105\u20131116 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016218_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/mi.2013.123","volume":"7","author":"HJ McSorley","year":"2014","unstructured":"McSorley, H. J., Blair, N. F., Smith, K. A., McKenzie, A. N. & Maizels, R. M. Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol. 7, 1068\u20131078 (2014).","journal-title":"Mucosal Immunol."},{"key":"BFnrrheum2016218_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ni.2045","volume":"12","author":"YJ Chang","year":"2011","unstructured":"Chang, Y. J.  et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631\u2013638 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","volume":"134","author":"KR Bartemes","year":"2014","unstructured":"Bartemes, K. R., Kephart, G. M., Fox, S. J. & Kita, H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J. Allergy Clin. Immunol. 134, 671\u2013678.e4 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrrheum2016218_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","volume":"36","author":"TY Halim","year":"2012","unstructured":"Halim, T. Y., Krauss, R. H., Sun, A. C. & Takei, F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36, 451\u2013463 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR26","doi-asserted-by":"publisher","first-page":"170ra16","DOI":"10.1126\/scitranslmed.3005374","volume":"5","author":"BS Kim","year":"2013","unstructured":"Kim, B. S.  et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci. Transl Med. 5, 170ra16 (2013).","journal-title":"Sci. Transl Med."},{"key":"BFnrrheum2016218_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli, L. A.  et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045\u20131054 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature14115","volume":"519","author":"JR Brestoff","year":"2015","unstructured":"Brestoff, J. R.  et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242\u2013246 (2015).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR29","first-page":"23","volume":"28","author":"Y Huang","year":"2016","unstructured":"Huang, Y. & Paul, W. E. Inflammatory group 2 innate lymphoid cells. Int. Immunol. 28, 23\u201328 (2016).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2016218_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","volume":"508","author":"MG Constantinides","year":"2014","unstructured":"Constantinides, M. G., McDonald, B. D., Verhoef, P. A. & Bendelac. A. A committed precursor to innate lymphoid cells. Nature 508, 397\u2013401 (2014).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ni.3344","volume":"17","author":"IE Ishizuka","year":"2016","unstructured":"Ishizuka, I. E.  et al. Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue-inducer cell lineage. Nat. Immunol. 17, 269\u2013276 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ni.3318","volume":"17","author":"C Zhong","year":"2016","unstructured":"Zhong, C.  et al. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat. Immunol. 17, 169\u2013178 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nri3855","volume":"15","author":"N Serafini","year":"2015","unstructured":"Serafini, N., Vosshenrich, C. A. & Di Santo, J. P. Transcriptional regulation of innate lymphoid cell fate. Nat. Rev. Immunol. 15, 415\u2013428 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4049\/jimmunol.1202924","volume":"190","author":"A Gladiator","year":"2013","unstructured":"Gladiator, A., Wangler, N., Trautwein-Weidner, K. & LeibundGut-Landmann, S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 190, 521\u2013525 (2013).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/mi.2013.101","volume":"7","author":"IH Chan","year":"2014","unstructured":"Chan, I. H.  et al. Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol. 7, 842\u2013856 (2014).","journal-title":"Mucosal Immunol."},{"key":"BFnrrheum2016218_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature11535","volume":"491","author":"S Huber","year":"2012","unstructured":"Huber, S.  et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259\u2013263 (2012).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1084\/jem.20091509","volume":"207","author":"NK Crellin","year":"2010","unstructured":"Crellin, N. K., Trifari, S., Kaplan, C. D., Cupedo, T. & Spits, H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281\u2013290 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016218_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo, T.  et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10, 66\u201374 (2009).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri1054","volume":"3","author":"RE Mebius","year":"2003","unstructured":"Mebius, R. E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3, 292\u2013303 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ni.3482","volume":"17","author":"H Spits","year":"2016","unstructured":"Spits, H., Bernink, J. H. & Lanier, L. NK cells and type 1 innate lymphoid cells: partners in host defense. Nat. Immunol. 17, 758\u2013764 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1074-7613(00)80371-4","volume":"7","author":"RE Mebius","year":"1997","unstructured":"Mebius, R. E., Rennert, P. & Weissman, I. L. Developing lymph nodes collect CD4+CD3- LT\u03b2+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493\u2013504 (1997).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ni.3059","volume":"16","author":"G Eberl","year":"2015","unstructured":"Eberl, G., Di Santo, J. P. & Vivier, E. The brave new world of innate lymphoid cells. Nat. Immunol. 16, 1\u20135 (2015).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ni.2002","volume":"12","author":"S Sawa","year":"2011","unstructured":"Sawa, S.  et al. ROR\u03b3t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320\u2013326 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature13158","volume":"508","author":"SA van de Pavert","year":"2014","unstructured":"van de Pavert, S. A.  et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508, 123\u2013127 (2014).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR45","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","volume":"196","author":"F Roan","year":"2016","unstructured":"Roan, F.  et al. CD4+ group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis. J. Immunol. 196, 2051\u20132062 (2016).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ni.3094","volume":"16","author":"ML Robinette","year":"2015","unstructured":"Robinette, M. L.  et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16, 306\u2013317 (2015).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri.2015.18","volume":"16","author":"M DuPage","year":"2016","unstructured":"DuPage, M. & Bluestone, J. A. Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease. Nat. Rev. Immunol. 16, 149\u2013163 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","volume":"494","author":"CS Klose","year":"2013","unstructured":"Klose, C. S.  et al. A T-bet gradient controls the fate and function of CCR6-ROR\u03b3t+ innate lymphoid cells. Nature 494, 261\u2013265 (2013).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink, J. H.  et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221\u2013229 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR50","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","volume":"17","author":"SM Bal","year":"2016","unstructured":"Bal, S. M.  et al. IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat. Immunol. 17, 636\u2013645 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR51","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ni.3443","volume":"17","author":"JS Silver","year":"2016","unstructured":"Silver, J. S.  et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat. Immunol. 17, 626\u201335 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.3447","volume":"17","author":"Y Ohne","year":"2016","unstructured":"Ohne, Y.  et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat. Immunol. 17, 646\u2013655 (2016).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nri3726","volume":"14","author":"G Gasteiger","year":"2014","unstructured":"Gasteiger, G. & Rudensky, A. Y. Interactions between innate and adaptive lymphocytes. Nat. Rev. Immunol. 14, 631\u2013639 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR54","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5483\/BMBRep.2016.49.5.023","volume":"49","author":"HS Kim","year":"2016","unstructured":"Kim, H. S.  et al. A novel IL-10-producing innate lymphoid cells (ILC10) in a contact hypersensitivity mouse model. BMB Rep. 49, 293\u2013296 (2016).","journal-title":"BMB Rep."},{"key":"BFnrrheum2016218_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H.  et al. Innate lymphoid cells \u2014 a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR56","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2016218_CR57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","volume":"2","author":"FM Brennan","year":"1989","unstructured":"Brennan, F. M., Chantry, D., Jackson, A., Maini, R. & Feldmann, M. Inhibitory effect of TNF \u03b1 antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2, 244\u2013247 (1989).","journal-title":"Lancet"},{"key":"BFnrrheum2016218_CR58","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/art.20303","volume":"50","author":"N Nishimoto","year":"2004","unstructured":"Nishimoto, N.  et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 50, 1761\u20131769 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016218_CR59","doi-asserted-by":"crossref","unstructured":"Edwards, C. J. Immunological therapies for rheumatoid arthritis. Br. Med. Bull. 73\u201374, 71\u201382 (2005).","DOI":"10.1093\/bmb\/ldh051"},{"key":"BFnrrheum2016218_CR60","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s13075-014-0467-3","volume":"16","author":"WP Kennedy","year":"2014","unstructured":"Kennedy, W. P.  et al. Efficacy and safety of pateclizumab (anti-lymphotoxin-\u03b1) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study). Arthritis Res. Ther. 16, 467 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016218_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/icb.2013.15","volume":"91","author":"EA Moelants","year":"2013","unstructured":"Moelants, E. A., Mortier, A., Van Damme, J. & Proost, P. Regulation of TNF-\u03b1 with a focus on rheumatoid arthritis. Immunol. Cell Biol. 91, 393\u2013401 (2013).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrrheum2016218_CR62","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3899\/jrheum.101377","volume":"38","author":"J Ren","year":"2011","unstructured":"Ren, J., Feng, Z., Ly, Z., Chen, X. & Li, J. Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-\u03b1. J. Rheumatol. 38, 2112\u20132118 (2011).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2016218_CR63","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4110\/in.2013.13.6.240","volume":"13","author":"J Koo","year":"2013","unstructured":"Koo, J.  et al. Increased lymphocyte infiltration in rheumatoid arthritis is correlated with an increase in LTi-like cells in synovial fluid. Immune Netw. 13, 240\u2013248 (2013).","journal-title":"Immune Netw."},{"key":"BFnrrheum2016218_CR64","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/art.10410","volume":"46","author":"N Dalbeth","year":"2002","unstructured":"Dalbeth, N. & Callan, M. F. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum. 46, 1763\u20131772 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016218_CR65","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.4049\/jimmunol.173.10.6418","volume":"173","author":"N Dalbeth","year":"2004","unstructured":"Dalbeth, N.  et al. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173, 6418\u20136426 (2004).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR66","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nri3349","volume":"13","author":"JA Walker","year":"2013","unstructured":"Walker, J. A., Barlow, J. L. & McKenzie, A. N. Innate lymphoid cells \u2014 how did we miss them? Nat. Rev. Immunol. 13, 75\u201387 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR67","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/art.39261","volume":"67","author":"EF Leijten","year":"2015","unstructured":"Leijten, E. F.  et al. Brief report: enrichment of activated group 3 innate lymphoid cells are selectively enriched in psoriatic arthritis synovial fluid. Arthritis Rheumatol. 67, 2673\u20132678 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2016218_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","volume":"74","author":"C Stolwijk","year":"2015","unstructured":"Stolwijk, C., van Tubergen, A., Castillo-Ortiz, J. D. & Boonen, A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann. Rheum. Dis. 74, 65\u201373 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016218_CR69","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten, D.  et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382, 1705\u20131713 (2013).","journal-title":"Lancet"},{"key":"BFnrrheum2016218_CR70","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten, D.  et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N. Engl. J. Med. 373, 2534\u20132548 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2016218_CR71","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","volume":"386","author":"IB McInnes","year":"2015","unstructured":"McInnes, I. B.  et al. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386, 1137\u20131146 (2015).","journal-title":"Lancet"},{"key":"BFnrrheum2016218_CR72","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","volume":"373","author":"PJ Mease","year":"2015","unstructured":"Mease, P. J.  et al. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N. Engl. J. Med. 373, 1329\u20131339 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2016218_CR73","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrrheum.2012.205","volume":"9","author":"TJ Kenna","year":"2013","unstructured":"Kenna, T. J. & Brown, M. A. The role of IL-17-secreting mast cells in inflammatory joint disease. Nat. Rev. Rheumatol. 9, 375\u2013379 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2016218_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/art.33396","volume":"64","author":"T Noordenbos","year":"2012","unstructured":"Noordenbos, T.  et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. Arthritis Rheum. 64, 99\u2013109 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016218_CR75","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel, H.  et al. Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res. Ther. 13, R95 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016218_CR76","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/annrheumdis-2015-eular.5907","volume":"74","author":"NN Yeremenko","year":"2015","unstructured":"Yeremenko, N. N.  et al. Human type 1 innate lymphoid cells accumulate in the inflamed synovium in spondyloarthritis [abstract AB0049]. Ann. Rheum. Dis. 74, 906 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016218_CR77","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1084\/jem.20101712","volume":"208","author":"A Geremia","year":"2011","unstructured":"Geremia, A.  et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 208, 1127\u20131133 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016218_CR78","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella, M.  et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722\u2013725 (2009).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/ni.2545","volume":"14","author":"LC Rankin","year":"2013","unstructured":"Rankin, L. C.  et al. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nat. Immunol. 14, 389\u2013395 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR80","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","volume":"37","author":"N Fullard","year":"2015","unstructured":"Fullard, N. & O'Reilly, S. Role of innate immune system in systemic sclerosis. Semin. Immunopathol. 37, 511\u2013517 (2015).","journal-title":"Semin. Immunopathol."},{"key":"BFnrrheum2016218_CR81","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/eci.11.40","volume":"7","author":"MR York","year":"2011","unstructured":"York, M. R. Novel insights on the role of the innate immune system in systemic sclerosis. Expert Rev. Clin. Immunol. 7, 481\u2013489 (2011).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrrheum2016218_CR82","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/annrheumdis-2015-207388","volume":"75","author":"T Wohlfahrt","year":"2016","unstructured":"Wohlfahrt, T.  et al. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Ann. Rheum. Dis. 75, 623\u2013626 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016218_CR83","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","volume":"126","author":"D Schepis","year":"2009","unstructured":"Schepis, D.  et al. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 126, 140\u2013146 (2009).","journal-title":"Immunology"},{"key":"BFnrrheum2016218_CR84","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2016.03.015","volume":"70","author":"C Braudeau","year":"2016","unstructured":"Braudeau, C.  et al. Persistent deficiency of circulating mucosal-associated invariant T (MAIT) cells in ANCA-associated vasculitis. J. Autoimmun. 70, 73\u201379 (2016).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum2016218_CR85","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri1786","volume":"6","author":"F Aloisi","year":"2006","unstructured":"Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6, 205\u2013217 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR86","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ni1330","volume":"7","author":"DL Drayton","year":"2006","unstructured":"Drayton, D. L., Liao, S., Mounzer, R. H. & Ruddle, N. H. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7, 344\u2013353 (2006).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016218_CR87","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.autrev.2007.03.006","volume":"7","author":"A Manzo","year":"2007","unstructured":"Manzo, A. & Pitzalis, C. Lymphoid tissue reactions in rheumatoid arthritis. Autoimmun. Rev. 7, 30\u201334 (2007).","journal-title":"Autoimmun. Rev."},{"key":"BFnrrheum2016218_CR88","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nri3700","volume":"14","author":"C Pitzalis","year":"2014","unstructured":"Pitzalis, C., Jones, G. W., Bombardieri, M. & Jones, S. A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14, 447\u2013462 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016218_CR89","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4049\/jimmunol.181.1.785","volume":"181","author":"T Cantaert","year":"2008","unstructured":"Cantaert, T.  et al. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J. Immunol. 181, 785\u2013794 (2008).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR90","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.cell.2014.04.016","volume":"157","author":"Y Okabe","year":"2014","unstructured":"Okabe, Y. & Medzhitov, R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157, 832\u2013844 (2014).","journal-title":"Cell"},{"key":"BFnrrheum2016218_CR91","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1172\/JCI71611","volume":"124","author":"NH Ruddle","year":"2014","unstructured":"Ruddle, N. H. Lymphatic vessels and tertiary lymphoid organs. J. Clin. Invest. 124, 953\u2013959 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016218_CR92","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fimmu.2012.00350","volume":"3","author":"S Stranford","year":"2012","unstructured":"Stranford, S. & Ruddle, N. H. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: parallels with lymph node stroma. Front. Immunol. 3, 350 (2012).","journal-title":"Front. Immunol."},{"key":"BFnrrheum2016218_CR93","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1126\/science.8171322","volume":"264","author":"P De Togni","year":"1994","unstructured":"De Togni, P.  et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703\u2013707 (1994).","journal-title":"Science"},{"key":"BFnrrheum2016218_CR94","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.1073\/pnas.1503315112","volume":"112","author":"F Barone","year":"2015","unstructured":"Barone, F.  et al. IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs. Proc. Natl Acad. Sci. USA 112, 11024\u201311029 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum2016218_CR95","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/ard.2011.154013","volume":"71","author":"F Ciccia","year":"2012","unstructured":"Ciccia, F.  et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann. Rheum. Dis. 71, 295\u2013301 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016218_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.imlet.2015.10.004","volume":"172","author":"CP Peters","year":"2016","unstructured":"Peters, C. P., Mjosberg, J. M., Bernink, J. H. & Spits, H. Innate lymphoid cells in inflammatory bowel diseases. Immunol. Lett. 172, 124\u2013131 (2016).","journal-title":"Immunol. Lett."},{"key":"BFnrrheum2016218_CR97","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","volume":"498","author":"MR Hepworth","year":"2013","unstructured":"Hepworth, M. R.  et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113\u2013117 (2013).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR98","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nature08949","volume":"464","author":"S Buonocore","year":"2010","unstructured":"Buonocore, S.  et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371\u20131375 (2010).","journal-title":"Nature"},{"key":"BFnrrheum2016218_CR99","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s00535-012-0591-2","volume":"47","author":"A Camelo","year":"2012","unstructured":"Camelo, A.  et al. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J. Gastroenterol. 47, 1198\u20131211 (2012).","journal-title":"J. Gastroenterol."},{"key":"BFnrrheum2016218_CR100","doi-asserted-by":"publisher","first-page":"e52332","DOI":"10.1371\/journal.pone.0052332","volume":"7","author":"JR Bailey","year":"2012","unstructured":"Bailey, J. R.  et al. IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? PLoS ONE 7, e52332 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2016218_CR101","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2010.10.012","volume":"33","author":"NK Crellin","year":"2010","unstructured":"Crellin, N. K.  et al. Regulation of cytokine secretion in human CD127+ LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33, 752\u2013764 (2010).","journal-title":"Immunity"},{"key":"BFnrrheum2016218_CR102","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1038\/jid.2014.216","volume":"134","author":"NL Ward","year":"2014","unstructured":"Ward, N. L. & Umetsu, D. T. A new player on the psoriasis block: IL-17A- and IL-22-producing innate lymphoid cells. J. Invest. Dermatol. 134, 2305\u20132307 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrrheum2016218_CR103","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2013.477","volume":"134","author":"F Villanova","year":"2014","unstructured":"Villanova, F.  et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J. Invest. Dermatol. 134, 984\u2013991 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrrheum2016218_CR104","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1016\/j.febslet.2011.05.025","volume":"585","author":"A Suzuki","year":"2011","unstructured":"Suzuki, A., Kochi, Y., Okada, Y. & Yamamoto, K. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS Lett. 585, 3627\u20133632 (2011).","journal-title":"FEBS Lett."},{"key":"BFnrrheum2016218_CR105","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502\u20131517 (2008).","journal-title":"Lancet"},{"key":"BFnrrheum2016218_CR106","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12026-015-8624-6","volume":"61","author":"F Safavi","year":"2015","unstructured":"Safavi, F.  et al. c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis. Immunol. Res. 61, 294\u2013302 (2015).","journal-title":"Immunol. Res."},{"key":"BFnrrheum2016218_CR107","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cellimm.2015.06.006","volume":"297","author":"JK Hatfield","year":"2015","unstructured":"Hatfield, J. K. & Brown, M. A. Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE. Cell. Immunol. 297, 69\u201379 (2015).","journal-title":"Cell. Immunol."},{"key":"BFnrrheum2016218_CR108","doi-asserted-by":"publisher","first-page":"145ra06","DOI":"10.1126\/scitranslmed.3004140","volume":"4","author":"JS Perry","year":"2012","unstructured":"Perry, J. S.  et al. Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis. Sci. Transl Med. 4, 145ra06 (2012).","journal-title":"Sci. Transl Med."},{"key":"BFnrrheum2016218_CR109","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.4049\/jimmunol.1500068","volume":"194","author":"AE Russi","year":"2015","unstructured":"Russi, A. E., Walker-Caulfield, M. E., Ebel, M. E. & Brown, M. A. Cutting edge: c-kit signaling differentially regulates type 2 innate lymphoid cell accumulation and susceptibility to central nervous system demyelination in male and female SJL mice. J. Immunol. 194, 5609\u20135613 (2015).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR110","doi-asserted-by":"publisher","first-page":"e45225","DOI":"10.1371\/journal.pone.0045225","volume":"7","author":"M Milovanovic","year":"2012","unstructured":"Milovanovic, M.  et al. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB\/C mice by enhancing polarization of APC to inflammatory phenotype. PLoS ONE 7, e45225 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrrheum2016218_CR111","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/eji.201141947","volume":"42","author":"HR Jiang","year":"2012","unstructured":"Jiang, H. R.  et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-\u03b3 production and inducing alternatively activated macrophages. Eur. J. Immunol. 42, 1804\u20131814 (2012).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2016218_CR112","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.molimm.2013.05.002","volume":"56","author":"A van Nieuwenhuijze","year":"2013","unstructured":"van Nieuwenhuijze, A.  et al. GM-CSF as a therapeutic target in inflammatory diseases. Mol. Immunol. 56, 675\u2013682 (2013).","journal-title":"Mol. Immunol."},{"key":"BFnrrheum2016218_CR113","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2014-205234","volume":"74","author":"DE Greven","year":"2015","unstructured":"Greven, D. E.  et al. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Ann. Rheum. Dis. 74, 1 924\u20131930 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016218_CR114","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrd3930","volume":"12","author":"M Croft","year":"2013","unstructured":"Croft, M., Benedict, C. A. & Ware, C. F. Clinical targeting of the TNF and TNFR superfamilies. Nat. Rev. Drug Discov. 12, 147\u2013168 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrrheum2016218_CR115","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/art.39685","volume":"68","author":"D van der Heijde","year":"2016","unstructured":"van der Heijde, D.  et al. Brief report: secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active psoriatic arthritis. Arthritis Rheumatol. 68, 1914\u20131921 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum2016218_CR116","doi-asserted-by":"publisher","first-page":"R182","DOI":"10.1186\/ar3507","volume":"13","author":"RA Fava","year":"2011","unstructured":"Fava, R. A.  et al. Lymphotoxin-\u03b2 receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sj\u00f6gren's syndrome. Arthritis Res. Ther. 13, R182 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016218_CR117","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4049\/jimmunol.171.1.115","volume":"171","author":"RA Fava","year":"2003","unstructured":"Fava, R. A.  et al. A role for the lymphotoxin\/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J. Immunol. 171, 115\u2013126 (2003).","journal-title":"J. Immunol."},{"key":"BFnrrheum2016218_CR118","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/ar2617","volume":"11","author":"MK Gatumu","year":"2009","unstructured":"Gatumu, M. K.  et al. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sj\u00f6gren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res. Ther. 11, R24 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016218_CR119","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MOG.0b013e328365d339","volume":"29","author":"A Fuchs","year":"2013","unstructured":"Fuchs, A. & Colonna, M. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract. Curr. Opin. Gastroenterol. 29, 581\u2013587 (2013).","journal-title":"Curr. Opin. Gastroenterol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.218","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:39:30Z","timestamp":1684471170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFnrrheum2016218"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2016.218","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]},"assertion":[{"value":"2 February 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}